|
Market Closed -
Nasdaq
01:30:00 15/08/2025 am IST
|
5-day change | 1st Jan Change | ||
| 100.99 USD | +0.01% |
|
-.--% | - |
| Market Cap | 332.12Cr 285.79Cr 268.89Cr 245.63Cr 459.5Cr 31TCr 460.75Cr 3.18TCr 1.23TCr 16TCr 1.25TCr 1.22TCr 52TCr | P/E 2023 |
-317x | P/E 2024 | 69.3x |
|---|---|---|---|---|---|
| Enterprise Value | 347.73Cr 299.22Cr 281.52Cr 257.17Cr 481.09Cr 33TCr 482.4Cr 3.33TCr 1.29TCr 17TCr 1.31TCr 1.28TCr 54TCr | EV / Sales 2023 |
1.55x | EV / Sales 2024 | 1.33x |
| Free-Float |
-
| Yield 2023 * |
-
| Yield 2024 | - |
| 30/25/30 | A CEO's Playbook For Navigating Crisis And Building Trust (Video) | AQ |
| 30/25/30 | Amedisys: Q2 Earnings Snapshot | AQ |
| 30/25/30 | Amedisys : Second Quarter 2025 Earnings Release Supplemental Slides | PU |
| 30/25/30 | Amedisys Reports Second Quarter 2025 Financial Results | AQ |
| 24/25/24 | Amedisys: Q1 Earnings Snapshot | AQ |
| 1 day | +0.01% |
| 3 years | 82.15 |  | 101.02 |
| 5 years | 69.36 | | 188.88 |
| 10 years | 34.58 | | 325.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Ginn
DFI | Director of Finance/CFO | 57 | 06/10/2017 |
Keith Blanchard
CTO | Chief Tech/Sci/R&D Officer | - | - |
Denise Bohnert
CMP | Compliance Officer | 48 | 01/01/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/08/25 | Issuer sale | Director | 9,818 | 0.0300% | ||
| 14/08/25 | Issuer sale | Director | 9,818 | 0.0300% | ||
| 14/08/25 | Issuer sale | Chief Executive Officer | 5,20,347 | 1.5886% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 223.64Cr 192.44Cr 181.06Cr 165.4Cr 309.41Cr 21TCr 310.25Cr 2.14TCr 830.23Cr 11TCr 839.78Cr 821.47Cr 35TCr | 234.83Cr 202.07Cr 190.12Cr 173.68Cr 324.9Cr 22TCr 325.78Cr 2.25TCr 871.79Cr 11TCr 881.82Cr 862.59Cr 37TCr |
| Net income | -97.47L -83.87L -78.91L -72.09L -1.35Cr -92Cr -1.35Cr -9.32Cr -3.62Cr -47Cr -3.66Cr -3.58Cr -152.11Cr | 4.32Cr 3.72Cr 3.5Cr 3.2Cr 5.98Cr 408.17Cr 6Cr 41Cr 16Cr 209.42Cr 16Cr 16Cr 674.65Cr |
| Net Debt | 36Cr 31Cr 29Cr 27Cr 50Cr 3.41TCr 50Cr 345.14Cr 133.93Cr 1.75TCr 135.47Cr 132.52Cr 5.63TCr | 16Cr 13Cr 13Cr 12Cr 22Cr 1.47TCr 22Cr 149.3Cr 58Cr 755.98Cr 59Cr 57Cr 2.44TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- AMED Stock
Select your edition
All financial news and data tailored to specific country editions
